NCT04119024 2026-03-17Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsStanford UniversityPhase 1 Recruiting18 enrolled
NCT00049023 2016-06-21Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid TumorsUniversity of IowaPhase 1 Completed27 enrolled
NCT00002947 2014-07-02Indium In 111 Pentetreotide in Treating Patients With Refractory CancerYale UniversityPhase 1 Terminated35 enrolled
NCT00006368 2013-05-01Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerNovartisPhase 1 Completed60 enrolled